Precigen, Inc. (PGEN) stock
PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.29−0.01 (-0.23%)
Close on Nov 17, 2026Market cap $1.54BP/E –Yield –
Precigen total assets
Total assets on the balance sheet at the end of each period.
Precigen's total assets was $170.30M at Jun 30, 2026. For fiscal 2025 it was $155.51M, up 7.0% from the year before. Over ten years it grew -16.8% a year on average. The highest annual figure on record is $982.05M in fiscal 2015.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $155.51M | +7.0% |
| FY2024 | Dec 31, 2024 | $145.27M | -3.8% |
| FY2023 | Dec 31, 2023 | $151.04M | -30.1% |
| FY2022 | Dec 31, 2022 | $215.98M | -40.0% |
| FY2021 | Dec 31, 2021 | $359.86M | +14.4% |
| FY2020 | Dec 31, 2020 | $314.59M | -31.0% |
| FY2019 | Dec 31, 2019 | $455.76M | -36.4% |
| FY2018 | Dec 31, 2018 | $716.18M | -15.4% |
| FY2017 | Dec 31, 2017 | $846.85M | -10.8% |
| FY2016 | Dec 31, 2016 | $949.07M | -3.4% |
| FY2015 | Dec 31, 2015 | $982.05M | +70.4% |
| FY2014 | Dec 31, 2014 | $576.27M | +22.7% |
| FY2013 | Dec 31, 2013 | $469.47M | +209.6% |
| FY2012 | Dec 31, 2012 | $151.65M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $170.30M | +67.1% |
| Q1 FY2026 | Mar 31, 2026 | $138.63M | +7.6% |
| Q4 FY2025 | Dec 31, 2025 | $155.51M | +7.0% |
| Q3 FY2025 | Sep 30, 2025 | $171.26M | +105.2% |
| Q2 FY2025 | Jun 30, 2025 | $101.90M | +39.3% |
| Q1 FY2025 | Mar 31, 2025 | $128.79M | -4.5% |
| Q4 FY2024 | Dec 31, 2024 | $145.27M | -3.8% |
| Q3 FY2024 | Sep 30, 2024 | $83.47M | -56.2% |
| Q2 FY2024 | Jun 30, 2024 | $73.16M | -64.7% |
| Q1 FY2024 | Mar 31, 2024 | $134.85M | -44.2% |
| Q4 FY2023 | Dec 31, 2023 | $151.04M | -30.1% |
| Q3 FY2023 | Sep 30, 2023 | $190.69M | -26.4% |
| Q2 FY2023 | Jun 30, 2023 | $207.53M | -35.4% |
| Q1 FY2023 | Mar 31, 2023 | $241.55M | -28.0% |
| Q4 FY2022 | Dec 31, 2022 | $215.98M | -40.0% |
| Q3 FY2022 | Sep 30, 2022 | $259.25M | -31.2% |
| Q2 FY2022 | Jun 30, 2022 | $321.22M | -20.2% |
| Q1 FY2022 | Mar 31, 2022 | $335.57M | -17.5% |
| Q4 FY2021 | Dec 31, 2021 | $359.86M | +14.4% |
| Q3 FY2021 | Sep 30, 2021 | $376.90M | +12.1% |
| Q2 FY2021 | Jun 30, 2021 | $402.57M | +11.3% |
| Q1 FY2021 | Mar 31, 2021 | $406.98M | +0.6% |
| Q4 FY2020 | Dec 31, 2020 | $314.59M | -31.0% |
| Q3 FY2020 | Sep 30, 2020 | $336.19M | -44.4% |
| Q2 FY2020 | Jun 30, 2020 | $361.72M | -44.8% |
| Q1 FY2020 | Mar 31, 2020 | $404.67M | -43.0% |
| Q4 FY2019 | Dec 31, 2019 | $455.76M | -36.4% |
| Q3 FY2019 | Sep 30, 2019 | $604.91M | -38.3% |
| Q2 FY2019 | Jun 30, 2019 | $655.19M | -20.6% |
| Q1 FY2019 | Mar 31, 2019 | $709.86M | -20.7% |
| Q4 FY2018 | Dec 31, 2018 | $716.18M | -15.4% |
| Q3 FY2018 | Sep 30, 2018 | $980.42M | +9.1% |
| Q2 FY2018 | Jun 30, 2018 | $825.15M | -11.7% |
| Q1 FY2018 | Mar 31, 2018 | $895.67M | -2.2% |
| Q4 FY2017 | Dec 31, 2017 | $846.85M | -10.8% |
| Q3 FY2017 | Sep 30, 2017 | $898.26M | -10.7% |
| Q2 FY2017 | Jun 30, 2017 | $933.99M | – |
| Q1 FY2017 | Mar 31, 2017 | $915.93M | – |
| Q4 FY2016 | Dec 31, 2016 | $949.07M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.01B | – |
See a number that looks wrong?